MongoDB (MDB) stock hit a 52-week high of $447.00 on August 13, currently trading at $452.89. That is a 114% gain over the past twelve months, a run that has turned heads across Wall Street.
The latest boost came from Oppenheimer, which on August 12 raised its price target on MDB from $410 to $475 while keeping an Outperform rating. That is a 15.85% jump in projected price from the same firm.
Other analysts are in a similar mood. Needham set a target of $430, pointing to AI spending as a tailwind for MongoDB. Tigress Financial went further, placing a $515 target on the stock and citing the company’s position in AI-powered data infrastructure.
Stifel raised its target to $435, crediting strong Atlas platform growth and accelerating consumption trends. Cantor Fitzgerald kept an Overweight rating with a $416 target, highlighting MongoDB’s role in the AI data stack.
The Q1 results that drove much of this optimism showed Atlas growing 29%, beating expectations by around 3%. Total revenue came in $23.1 million above estimates.
MongoDB’s market cap sits at approximately $35.2 billion. Revenue growth over the last twelve months is close to 24%. The price-to-sales ratio stands at around 16.3x, roughly in line with its historical median of 16.28x.
That said, MDB is not profitable. Its trailing twelve-month EPS is -$0.37, which means standard P/E valuation does not apply here.
GF Value puts the stock’s fair value at $387.49, suggesting MDB is trading about 13.7% above that level. Its GF Score of 83 out of 100 reflects strong growth and momentum rankings, but a low profitability score of 3 out of 10.
Not everything is pointing up. Insiders have sold $53.7 million worth of stock over the past three months, with zero insider buying recorded in that period.
Among institutional investors, 10 gurus currently hold MDB, with 4 adding to positions and 7 trimming. The picture is mixed.
Citigroup, Truist Securities, and Bank of America have all maintained Buy ratings with upward price target revisions. That broad analyst consensus keeps the overall tone positive despite the insider selling.
The stock’s GF Score of 83 shows strong fundamentals in growth and momentum, while flagging profitability as an ongoing weakness.
Oppenheimer’s revised $475 target remains one of the more recent data points on the table, published August 12, 2026.
The post MongoDB (MDB) Stock Hits 52-Week High as Analysts Raise Price Targets appeared first on CoinCentral.
